Omics study of critical ill patients for monitoring immune function and Immunomodulatory treatment

Single cell sequencing technology for monitoring immune function in heat stroke patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027492

Enrollment

Unknown

Registered

2019-11-15

Start date

2019-11-15

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heat stroke

Interventions

Case Series:N/A

Eligibility

Sex/Gender

Male

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) age: 16-60 years old; (2) according to the diagnostic criteria put forward by Leon in 2015 review, patients with heat stroke (HS) are defined as thermal diseases characterized by core temperature (Tc) exceeding 40.5°C and central nervous system dysfunction after exposure to high temperature and humidity or intense physical activity.

Exclusion criteria

Exclusion criteria: Patients with malignant diseases such as tumors; Those who had taken drugs to interfere with the immune system, such as hormones or immunosuppressive drugs, in the last 3 months; Virus carriers, such as AIDS, HBV, etc.

Design outcomes

Primary

Measure	Time frame
RNA sequence;	—

Secondary

Measure	Time frame
Blood Routine;Lymphocyte clusters;	—

Countries

China

Contacts

Public ContactZhifeng Liu

General Hospital of Southern Theatre Command

zhifengliu7797@163.com+86 13711598120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026